GlucoTrack Shares Surged After Partnership Deal
Lokahi Therapeutics signed a fee-for-service agreement to aid Innovate GBM with brain tumor asset identification.
Live Poll
Do you generally trust the long-term potential of small-cap biotech stocks after market-moving news?